News

News from Chiesi

2023-06-29T15:17:17+02:00

Chiesi Global Rare Diseases and Protalix BioTherapeutics Announce European Commission Authorization of PRX-102 (pegunigalsidase alfa) for the Treatment of Fabry Disease

News from Chiesi2023-06-29T15:17:17+02:00
Go to Top